These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 12056065

  • 21. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA.
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 28. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 29. Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.
    Terzano C, Petroianni A, Ricci A, Allegra L.
    Eur Rev Med Pharmacol Sci; 2005 Apr; 9(4):209-15. PubMed ID: 16128040
    [Abstract] [Full Text] [Related]

  • 30. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH.
    Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?
    Burge PS, Lewis SA.
    Thorax; 2003 Nov 28; 58(11):911-3. PubMed ID: 14586036
    [No Abstract] [Full Text] [Related]

  • 34. Translating Pharmacometrics to a Pharmacoeconomic Model of COPD.
    Slejko JF, Willke RJ, Ribbing J, Milligan P.
    Value Health; 2016 Dec 28; 19(8):1026-1032. PubMed ID: 27987629
    [Abstract] [Full Text] [Related]

  • 35. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research.
    Wanner A, Mendes ES.
    Am J Respir Crit Care Med; 2010 Dec 01; 182(11):1344-51. PubMed ID: 20709816
    [Abstract] [Full Text] [Related]

  • 36. Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?
    Sin DD, Man SF.
    Eur Respir J; 2005 Apr 01; 25(4):589-90. PubMed ID: 15802328
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Exhaled nitric oxide and steroid responses in chronic obstructive pulmonary disease.
    Kunisaki KM.
    Am J Respir Crit Care Med; 2010 Mar 01; 181(5):523-4. PubMed ID: 20185753
    [No Abstract] [Full Text] [Related]

  • 40. Update in Chronic Obstructive Pulmonary Disease 2014.
    Seemungal TA, Wedzicha JA.
    Am J Respir Crit Care Med; 2015 Nov 01; 192(9):1036-44. PubMed ID: 26517417
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.